Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9…
Seraphim Awarded ‘Top Performer’ in Kiwa PVEL’s 2025 PV Module Reliability Scorecard for Sixth Time
SHANGHAI, June 11, 2025 /PRNewswire/ -- Recently, Kiwa PV Evolution Labs (Kiwa PVEL), a…
